Compliance, safety concerns and anxiety in patients treated with biologics for psoriasis during the COVID-19 pandemic national lockdown: a multicenter study in the Czech Republic.
作者信息
Rob F, Hugo J, Tivadar S, Boháč P, Gkalpakiotis S, Vargová N, Arenbergerová M, Hercogová J
机构信息
Dermatovenereology Department, Second Faculty of Medicine, Na Bulovce Hospital, Charles University, Prague, Czech Republic.
Dermatovenereology Department, Third Faculty of Medicine, Kralovske Vinohrady University Hospital, Charles University, Prague, Czech Republic.
出版信息
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e682-e684. doi: 10.1111/jdv.16771. Epub 2020 Jul 9.
Abstract
摘要
相似文献
1
Compliance, safety concerns and anxiety in patients treated with biologics for psoriasis during the COVID-19 pandemic national lockdown: a multicenter study in the Czech Republic.新冠疫情全国封锁期间接受生物制剂治疗的银屑病患者的依从性、安全担忧及焦虑：捷克共和国的一项多中心研究
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e682-e684. doi: 10.1111/jdv.16771. Epub 2020 Jul 9.
2
Safety of biologics for psoriasis patients during the COVID-19 pandemic: the experience from Wuhan, China.新冠疫情期间生物制剂治疗银屑病患者的安全性：来自中国武汉的经验
Eur J Dermatol. 2020 Dec 1;30(6):738-740. doi: 10.1684/ejd.2020.3908.
3
A survey of psoriasis patients on biologics during COVID-19: a high-epidemic area experience - Franche Comté, France.新冠疫情期间法国弗朗什-孔泰大区银屑病生物制剂治疗患者的调查
Eur J Dermatol. 2021 Feb 1;31(1):101-103. doi: 10.1684/ejd.2020.3960.
4
Beliefs About Medicines in Patients with Psoriasis Treated with Methotrexate or Biologics: A Cross-sectional Survey Study.接受甲氨蝶呤或生物制剂治疗的银屑病患者对药物的信念：一项横断面调查研究。
Acta Derm Venereol. 2019 Apr 1;99(4):386-392. doi: 10.2340/00015555-3108.
5
Severe Acute Respiratory Syndrome Coronavirus 2 and the Use of Biologics in Patients With Psoriasis [Formula: see text].严重急性呼吸综合征冠状病毒 2 与银屑病患者生物制剂的使用 [公式：见正文]。
J Cutan Med Surg. 2020 Nov/Dec;24(6):625-632. doi: 10.1177/1203475420945234. Epub 2020 Aug 6.
6
Immunosuppressive drugs for patients with psoriasis during the COVID-19 pandemic era. A review.COVID-19 大流行时期银屑病患者的免疫抑制药物。综述。
Dermatol Ther. 2021 Jan;34(1):e14498. doi: 10.1111/dth.14498. Epub 2020 Nov 10.
7
Rate of Patient-Driven Biologic Treatment Discontinuation During the COVID-19 Pandemic in 2 Academic Hospital Clinics at the University of Toronto.多伦多大学两所学术医院诊所中COVID-19大流行期间患者驱动的生物治疗停药率。
J Cutan Med Surg. 2020 Jul/Aug;24(4):424-425. doi: 10.1177/1203475420930226. Epub 2020 Jun 1.
8
Biologic drugs during COVID-19 outbreak.2019冠状病毒病疫情期间的生物药物
Int J Dermatol. 2020 Oct;59(10):1293. doi: 10.1111/ijd.15088. Epub 2020 Aug 6.
9
Surveillance of psoriatic patients on biologic treatment during the COVID-19 pandemic: A single-center experience.COVID-19 大流行期间生物治疗的银屑病患者监测：单中心经验。
Dermatol Ther. 2021 Jan;34(1):e14700. doi: 10.1111/dth.14700. Epub 2020 Dec 28.
10
Understanding views of patients on biologics for psoriasis amid the COVID-19 pandemic.
J Eur Acad Dermatol Venereol. 2021 Apr;35(4):e249-e251. doi: 10.1111/jdv.17091. Epub 2020 Dec 29.
引用本文的文献
1
Perception and Impact of COVID-19 Pandemic in Psoriasis Patients: Data from the German PsoBest and the CoronaBest Registries.新冠疫情对银屑病患者的认知与影响：来自德国PsoBest和CoronaBest注册研究的数据
Psoriasis (Auckl). 2024 May 14;14:29-38. doi: 10.2147/PTT.S451666. eCollection 2024.
2
A systematic review and meta-analysis of investigating the mutual impact of COVID-19 and psoriasis: Focusing on COVID-19 course in psoriasis and the opinion on biologics in this setting.一项关于探究2019冠状病毒病（COVID-19）与银屑病相互影响的系统评价和荟萃分析：聚焦银屑病患者的COVID-19病程及在此背景下对生物制剂的看法。
Immun Inflamm Dis. 2023 Nov;11(11):e1063. doi: 10.1002/iid3.1063.
3
The Psoriasis Disability Index in Romanian Psoriasis Patients during COVID-19 Pandemic: Contribution of Clinical and Psychological Variables.新冠疫情期间罗马尼亚银屑病患者的银屑病残疾指数：临床和心理变量的作用
J Clin Med. 2023 Sep 16;12(18):6000. doi: 10.3390/jcm12186000.
4
Treatment Adherence in Dermatology During the COVID-19 Pandemic: A Review.COVID-19大流行期间皮肤科的治疗依从性：一项综述
Cureus. 2023 Jan 24;15(1):e34141. doi: 10.7759/cureus.34141. eCollection 2023 Jan.
5
Impact of the First SARS-CoV-2 Lockdown on Adherence to Biological Treatment in Patients with Immune-Mediated Inflammatory Diseases in the Netherlands.荷兰首次实施新冠病毒封锁对免疫介导性炎症疾病患者生物治疗依从性的影响。
Patient Prefer Adherence. 2023 Jan 19;17:167-174. doi: 10.2147/PPA.S392290. eCollection 2023.
6
Psoriasis Flares in Patients With COVID-19 Infection or Vaccination: A Case Series.新型冠状病毒肺炎感染或接种疫苗患者的银屑病发作：病例系列
Cureus. 2022 Jun 16;14(6):e25987. doi: 10.7759/cureus.25987. eCollection 2022 Jun.
7
Skin Manifestations in Psoriatic and HS Patients in Treatment with Biologicals during the COVID-19 Pandemic.新冠疫情期间接受生物制剂治疗的银屑病和化脓性汗腺炎患者的皮肤表现
J Clin Med. 2021 Dec 13;10(24):5841. doi: 10.3390/jcm10245841.
8
Adherence to systemic therapy in patients with psoriasis during the COVID-19 pandemic: A multicenter study.COVID-19 大流行期间银屑病患者对系统性治疗的依从性：一项多中心研究。
J Cosmet Dermatol. 2022 Jan;21(1):39-47. doi: 10.1111/jocd.14610. Epub 2021 Nov 18.
9
Psoriasis flare-up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine.与辉瑞-生物科技公司的第二剂BNT16B2b2新冠mRNA疫苗相关的银屑病发作。
J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e632-e634. doi: 10.1111/jdv.17449. Epub 2021 Jun 24.
10
Psoriasis care during the time of COVID-19: real-world data on changes in treatments and appointments from a German university hospital.新冠疫情期间的银屑病护理：来自德国一家大学附属医院的治疗和预约变化的真实世界数据。
Eur J Dermatol. 2021 Apr 1;31(2):183-191. doi: 10.1684/ejd.2021.4016.
本文引用的文献
1
Should biologics for psoriasis be interrupted in the era of COVID-19?在新冠疫情时代，银屑病生物制剂是否应中断使用？
J Am Acad Dermatol. 2020 May;82(5):1217-1218. doi: 10.1016/j.jaad.2020.03.031. Epub 2020 Mar 19.
2
COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action.新型冠状病毒肺炎与银屑病：是时候限制免疫抑制剂的使用了吗？呼吁采取行动。
Dermatol Ther. 2020 Jul;33(4):e13298. doi: 10.1111/dth.13298. Epub 2020 Mar 22.
3
US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey.美国银屑病和银屑病关节炎管理视角：基于人群的银屑病和银屑病关节炎多国评估（MAPP）调查中的患者及医生结果
Am J Clin Dermatol. 2016 Feb;17(1):87-97. doi: 10.1007/s40257-015-0169-x.
4
A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory Diseases.免疫介导性炎症疾病治疗不依从相关因素的系统评价
Adv Ther. 2015 Nov;32(11):983-1028. doi: 10.1007/s12325-015-0256-7. Epub 2015 Nov 7.
5
Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A).焦虑测量工具：状态-特质焦虑量表（STAI）、贝克焦虑量表（BAI）以及医院焦虑抑郁量表-焦虑分量表（HADS-A）。
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11(0 11):S467-72. doi: 10.1002/acr.20561.
Zotero 插件